Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom
Top Cited Papers
Open Access
- 1 December 2002
- journal article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 87 (6) , 457-461
- https://doi.org/10.1136/adc.87.6.457
Abstract
Background: Until recently, only two cases of acute adrenal crisis associated with inhaled corticosteroids (ICS) had been reported worldwide. We identified four additional cases and sought to survey the frequency of this side effect in the United Kingdom. Methods: Questionnaires were sent to all consultant paediatricians and adult endocrinologists registered in a UK medical directory, asking whether they had encountered asthmatic patients with acute adrenal crisis associated with ICS. Those responding positively completed a more detailed questionnaire. Diagnosis was confirmed by symptoms/signs and abnormal hypothalamic-pituitary-adrenal axis function test results. Results: From an initial 2912 questionnaires, 33 patients met the diagnostic criteria (28 children, five adults). Twenty-three children had acute hypoglycaemia (13 with decreased levels of consciousness or coma; nine with coma and convulsions; one with coma, convulsions and death); five had insidious onset of symptoms. Four adults had insidious onset of symptoms; one had hypoglycaemia and convulsions. Of the 33 patients treated with 500–2000 μg/day ICS, 30 (91%) had received fluticasone, one (3%) fluticasone and budesonide, and two (6%) beclomethasone. Conclusions: The frequency of acute adrenal crisis was greater than expected as the majority of these patients were treated with ICS doses supported by British Guidelines on Asthma Management. Despite being the least prescribed and most recently introduced ICS, fluticasone was associated with 94% of the cases. We therefore advise that the licensed dosage of fluticasone for children, 400 μg/day, should not be exceeded unless the patient is being supervised by a physician with experience in problematic asthma. We would also emphasise that until adrenal function has been assessed patients receiving high dose ICS should not have this therapy abruptly terminated as this could precipitate adrenal crisis.Keywords
This publication has 27 references indexed in Scilit:
- Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patientsAnnals of Allergy, Asthma & Immunology, 2001
- Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis Commentary: Dosage needs systematic and criticalBMJ, 2001
- Why Particle Size Should Affect Clinical Response to Inhaled TherapyJournal of Aerosol Medicine, 2001
- Importance of drug-device interaction in determining systemic effects of inhaled cor ticosteroidsThe Lancet, 1999
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Pharmacodynamics and pharmacokinetics of inhaled glucocorticoidsJournal of Allergy and Clinical Immunology, 1996
- Aerosol Particle Generation from Dry Powder Inhalers: Can They Equal Pressurized Metered Dose Inhalers?Journal of Aerosol Medicine, 1995
- Cough--but is it asthma?Archives of Disease in Childhood, 1994
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- Acute adrenal insufficiency associated with high dose inhaled steroids.BMJ, 1992